Domo signs strategic collaboration agreement with AWS for AI solutions
Evan Roberts, the Chief Operating Officer of Phreesia, Inc. (NYSE:PHR), a healthcare software company with a market capitalization of $1.4 billion and impressive revenue growth of ~18% over the last twelve months, recently sold a portion of his holdings in the company, according to a regulatory filing. On April 8, Roberts disposed of a total of 7,233 shares of common stock in two separate transactions. The shares were sold at prices ranging from $23.4568 to $24.475 per share, amounting to a total value of $172,527. According to InvestingPro data, the stock currently trades near $24, with analysts setting price targets between $29 and $36.
These transactions were carried out as part of Phreesia's mandatory sell-to-cover policy, which requires stockholders to sell shares to cover tax obligations associated with the settlement of restricted stock units. Following these sales, Roberts retains ownership of 776,652 shares in the company. InvestingPro analysis shows the company appears undervalued, with multiple analysts revising earnings estimates upward for the upcoming period. Get detailed insights and 6 additional ProTips with an InvestingPro subscription.
In other recent news, Phreesia Inc . has seen several notable developments. Jefferies raised its price target for Phreesia from $28.00 to $32.00, citing confidence in the company's growth prospects and operational leverage. This follows an analysis of Phreesia's fourth-quarter earnings and management's commentary. Meanwhile, KeyBanc Capital Markets maintained its Overweight rating with a $30.00 price target, praising Phreesia's margin improvements and focus on Network Solutions as drivers for future growth. Raymond (NSE:RYMD) James also reiterated an Outperform rating with a $30.00 price target, emphasizing Phreesia's transition to a more free cash flow-oriented approach. DA Davidson continues to support Phreesia with a Buy rating and a $36.00 price target, highlighting the company's consistent performance and potential for profit improvement. These updates reflect a positive outlook from analysts regarding Phreesia's financial health and strategic direction.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.